bioRxivMicrobiologyPreprint
Targeted repression of DNA topoisomerase I by CRISPRi reveals a critical function for it in the Chlamydia trachomatis developmental cycle
Abstract
Chlamydia trachomatis is an obligate intracellular bacterium that is responsible for the most prevalent bacterial sexually transmitted infections. Changes in DNA topology in this pathogen have been linked to its pathogenicity-associated developmental cycle. Here, evidence is provided that the balanced activity of DNA topoisomerases (Topos) contributes to Chlamydia developmental processes. Utilizing catalytically inactivated Cas12 (dCas12) based-clustered regularly interspaced short palindromic repeats interference (CRISPRi) technology, we demonstrate targeted knockdown of chromosomal topA transcription in C. trachomatis without detected toxicity of dCas12. Repression of topA impaired the growth of C. trachomatis mostly through disruption of its differentiation from a replicative form to an infectious form. Consistent with this, expression of late developmental genes of C. trachomatis was downregulated while early genes maintained their expression. Importantly, the growth defect associated with topA knockdown was rescued by overexpressing topA at an appropriate degree and time, directly linking the growth patterns to the levels of topA expression. Interestingly, topA knockdown had pleiotropic effects on DNA gyrase expression, indicating a potential compensatory mechanism for survival to offset TopA deficiency. C. trachomatis with topA knocked down displayed hypersensitivity to moxifloxacin that targets DNA gyrase in comparison with the wild type. These data underscore the requirement of integrated topoisomerase actions to support the essential development and transcriptional processes of C. trachomatis. ImportanceWe used genetic and chemical tools to demonstrate the relationship of topoisomerase activities and their obligatory role for the chlamydial developmental cycle. Successfully targeting the essential gene topA with a CRISPRi approach, using dCas12, in C. trachomatis indicates that this method will facilitate the characterization of the essential genome. These findings have an important impact on our understanding of the mechanism(s) by which well-balanced topoisomerase activities enable C. trachomatis to adapt to unfavorable growth conditions imposed by antibiotics.
- organism: C. elegans
- research focus: cell type annotation
- research focus: development & morphogenesis
- research focus: gene regulatory network inference
- research focus: drug response / drug discovery
- approach: genetic perturbation / CRISPR
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- The SWIB domain-containing DNA topoisomerase I of Chlamydia trachomatis mediates DNA relaxation
Li Shen, Abigail R. Swoboda, … Yuk‐Ching Tse‐Dinh·Journal of BacteriologyPeer-reviewed·Aug 12, 2025
- The ClpX and ClpP2 Orthologs of Chlamydia trachomatis Perform Discrete and Essential Functions in Organism Growth and Development
N. A. Wood, A. Blocker, … S. P. Ouellette·mBioPeer-reviewed·Oct 27, 2020
- Coordinated topoisomerase function shapes the fluoroquinolone response of Chlamydia trachomatis
Andrew Terrebonne, Caitlynn Diggs, … Li Shen·Microbiology SpectrumPeer-reviewed·Aug 27, 2026
- GrgA controls Chlamydia trachomatis growth and development by regulating expression of transcription factors Euo and HrcA
Wurihan Wurihan, Yi Zou, … Huizhou Fan·bioRxiv·Jul 8, 2020
- Identification of the alternative sigma factor regulons of Chlamydia trachomatis using multiplexed CRISPR interference
N. D. Hatch, S. P. Ouellette·bioRxiv·Apr 27, 2023
- Requirement of GrgA for Chlamydia infectious progeny production, optimal growth, and efficient plasmid maintenance